Posted by
Paul Fletcher
10 Comments
China and India dominate global pharmaceutical manufacturing, but their FDA compliance and supply chain risks differ sharply. India leads in regulatory reliability, while China dominates in scale and APIs - yet both face serious challenges.
read more